about
Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive breast cancer: Where we are now and where we are goingImpact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.Gamma Knife Radiosurgery in the management of single and multiple brain metastases.A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis.A PPAR-gamma agonist protects from radiation-induced intestinal toxicity.Management of inflammatory breast cancer: focus on radiotherapy with an evidence-based approach.Hypofractionation in prostate cancer: radiobiological basis and clinical appliance.Radiotherapy in the age of cancer immunology: Current concepts and future developments.Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series.Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience.Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study.Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature.SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab.Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial.Impact of sentinel node tumor burden on outcome of invasive breast cancer patients.Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer.Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review.Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice.Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles.Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University.Stereotactic body radiotherapy with CyberKnife for cardiac malignancies.A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model.Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?Accuracy of Orthopantomography for Apical Periodontitis without Endodontic Treatment.Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting.Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience.Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO).Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions.Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literatureSingle-Fraction Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Relapse in Prostate CancerAssessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy : Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014)Efficacy and Tolerability of CyberKnife Stereotactic Robotic Radiotherapy for Primary or Secondary Orbital Lesions: A Single-Center Retrospective ExperienceAnalysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatmentA national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policyA multiparametric method to assess the MIM deformable image registration algorithm
P50
Q26750740-DB14D049-015B-4E5B-AC89-8634DA049508Q30240601-AB4D72D1-9E24-4986-B447-75C8C54FE4A2Q35885609-BF1719BE-2863-4843-8C34-93336E3A3925Q36280675-138E8E64-6C97-4EF6-895A-DC43156A620BQ37698546-334F529C-E95D-4ED1-8F75-5869C8FE8053Q38008092-5A6E8307-60C8-4EA3-A561-D3D4CE0ECF1AQ38226822-E283B47B-1978-4075-BC84-1F9647B854ADQ38742020-7F299DD3-F1FC-405B-853D-1A79E9782E01Q38750321-CC20C298-9D12-4156-9B96-C3F6E86E4299Q38849891-6F720E3F-FD2D-4FE9-B19F-BFA9153F0D99Q38897959-630AB542-A6ED-43A7-9299-9A6E6ACA0F05Q38913042-81443EF2-3E35-476A-912D-2A3FC3A90B6DQ38958436-00BA266F-047E-4727-AF92-C2EBB1ED7730Q39212333-5C003EDB-2E3F-44D6-B355-8F61141882ABQ39212340-4B2DF947-BA3F-43D8-AB3F-6802F1F947F3Q41387966-2B2F225E-BADF-4875-B3A2-2450DD39F627Q43587647-51DC1C8E-659A-419B-84F7-4BC16F60550DQ47363506-1CD219C0-DBAD-47A4-B1DA-505F77ACDA81Q47378837-848FCC31-2DF5-4C47-BE83-D9290C68AA36Q47385024-6CFD5A7B-A89C-4F0C-A1D8-2880F9830477Q47583052-58722664-7A9C-4890-8D7B-C4A0A8C88F7EQ47774112-5A115A04-1794-435B-A54C-B8E9B9684664Q48611309-2A61CF02-AFFD-4EE5-B2EF-BEA4CDDA96A8Q50753662-63B73D40-8BE7-4F36-8E12-24298CE34DEBQ50926119-DA2F916F-1717-44CF-A76D-484141D141D6Q51235074-0B1521E7-0BC5-4225-87B8-02C2AAB149C5Q52628817-73861095-3C67-4DAB-AD6B-A9556735A148Q53111973-385B5636-85F2-42DC-ACA3-74DC74A762F1Q54312389-ECBB8FBB-DEB9-4CEA-B9AF-E7D44783C82AQ54459895-BE5AF53D-66B1-4DE8-8C1C-373C2E4EBAD3Q54982410-EE56E07C-46C7-4CF3-AFA3-5B28B2E96EF0Q55457101-3B8A85FA-AEE6-4DBF-B54F-7D5A50332D3CQ57181170-C1424AB8-8001-4737-9EEE-1A28D19AB70AQ57469449-2D10008A-02C5-4C09-A1C1-2F0F35994A97Q58603206-FDF55C58-6E52-4CD1-AE9D-E205300E903BQ61810611-C810CEAE-1E7A-49BA-9193-E75899FD9983Q62062936-BF597200-F738-4A05-9AB7-BB1F30CDC6C8Q62693648-A321DF6B-AFB9-47D4-B1A8-B8CB08BF3317Q63532663-00409259-0560-47C0-A2E6-258D1D3ECD52Q64107653-7C33577A-0C14-4E25-9F55-A79F4A4DBF72
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Isacco Desideri
@ast
Isacco Desideri
@en
Isacco Desideri
@es
Isacco Desideri
@nl
Isacco Desideri
@sl
type
label
Isacco Desideri
@ast
Isacco Desideri
@en
Isacco Desideri
@es
Isacco Desideri
@nl
Isacco Desideri
@sl
prefLabel
Isacco Desideri
@ast
Isacco Desideri
@en
Isacco Desideri
@es
Isacco Desideri
@nl
Isacco Desideri
@sl
P106
P31
P496
0000-0002-9880-8387